183 related articles for article (PubMed ID: 16884995)
1. Management of anticoagulation for coronary artery bypass surgery in a patient with severe prekallikrein deficiency.
Oram MP; Mumford AD; Morse C; Underwood S
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):580-2. PubMed ID: 16884995
[No Abstract] [Full Text] [Related]
2. Management of prekallikrein deficiency during cardiac surgery.
Eeckhoudt SL; Momeni M; Matta A; Latinne D; Arnout J; Hermans C
Thromb Haemost; 2010 Apr; 103(4):866-7. PubMed ID: 20135073
[No Abstract] [Full Text] [Related]
3. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
van Veen JJ; Laidlaw S; Swanevelder J; Harvey N; Watson C; Kitchen S; Makris M
Eur J Haematol; 2009 Mar; 82(3):208-12. PubMed ID: 19077049
[TBL] [Abstract][Full Text] [Related]
4. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time.
Cankovic L; Steenwyk BL; McGiffin DC; Nielsen VG
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):725-6. PubMed ID: 18832918
[TBL] [Abstract][Full Text] [Related]
5. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the anti-Xa anticoagulants, from heparin to eliquis.
Fritsma GA
Clin Lab Sci; 2013; 26(1):48-53. PubMed ID: 23479837
[No Abstract] [Full Text] [Related]
7. Implications for cardiac surgery in patients with factor XII deficiency.
Conaglen PJ; Akowuah E; Theodore S; Atkinson V
Ann Thorac Surg; 2010 Feb; 89(2):625-6. PubMed ID: 20103363
[TBL] [Abstract][Full Text] [Related]
8. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
9. Coagulation assays.
Bates SM; Weitz JI
Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
[No Abstract] [Full Text] [Related]
10. Monitoring of systemic anticoagulation during cardiopulmonary bypass.
Bidstrup BP
Ann Thorac Surg; 1996 Mar; 61(3):781-2. PubMed ID: 8619692
[No Abstract] [Full Text] [Related]
11. Lupus anticoagulant and off-pump coronary bypass: dilemma of anticoagulation.
Maddali MM; Albahrani MJ
Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):246-8. PubMed ID: 17540998
[TBL] [Abstract][Full Text] [Related]
12. Management of a patient with lupus anticoagulant and antiphospholipid syndrome for off-pump coronary artery bypass grafting using the Hepcon system.
Jervis K; Senthilnathan V; Lerner AB
Anesth Analg; 2009 Apr; 108(4):1116-9. PubMed ID: 19299773
[TBL] [Abstract][Full Text] [Related]
13. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
Greaves M;
Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
[No Abstract] [Full Text] [Related]
14. Intraoperative antiaggregant strategy for off-pump coronary artery bypass grafting in a patient with heparin-induced thrombocytopenia.
Zanobini M; Barili F; Alamanni F; Dainese L; Stringi V; Cappai A; Dell'orto M; Porqueddu M; Roberto M; Kassem S; Pompilio G; Biglioli P
Heart Surg Forum; 2008; 11(1):E54-5. PubMed ID: 18270143
[TBL] [Abstract][Full Text] [Related]
15. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
[TBL] [Abstract][Full Text] [Related]
16. Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery.
Hendrice C; Schmartz D; Pradier O; Coron T; Kucharcezwski C; d'Hollander A; Capel P
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):245-9. PubMed ID: 7545449
[TBL] [Abstract][Full Text] [Related]
17. Prekallikrein (Fletcher factor) deficiency.
Sollo DG; Saleem A
Ann Clin Lab Sci; 1985; 15(4):279-85. PubMed ID: 3849948
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
[TBL] [Abstract][Full Text] [Related]
19. Isolated prolonged activated partial thromboplastin time in an asymptomatic patient: Fletcher factor deficiency.
Acar K; Yağci M; Sucak GT; Haznedar R
Thromb Res; 2006; 118(6):765-6. PubMed ID: 16414101
[No Abstract] [Full Text] [Related]
20. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
